Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Plan A Occlusion and Reversal System Feasibility Study

NCT: NCT07361120 · RECRUITING

NCT IDNCT07361120
StatusRECRUITING
Start Date2026-01-15
Completion2026-12
SponsorNext Life Sciences (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive System to occlude the vas deferens to block the passage of sperm and then be reversed to subsequently allow the passage of sperm through the vas deferens.

Frequently Asked Questions

What is Plan A Occlusion and Reversal System Feasibility Study?

Plan A Occlusion and Reversal System Feasibility Study is a clinical trial registered under NCT07361120. Current status: RECRUITING.

What is the status of NCT07361120?

The current status of NCT07361120 (Plan A Occlusion and Reversal System Feasibility Study) is: RECRUITING.

When did Plan A Occlusion and Reversal System Feasibility Study start?

Plan A Occlusion and Reversal System Feasibility Study started on 2026-01-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.